Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Ann Dermatol Venereol ; 146(4): 287-291, 2019 Apr.
Article in French | MEDLINE | ID: mdl-30691878

ABSTRACT

BACKGROUND: Toxic shock syndrome (TSS) was first described by Todd in 1978. The relevant Lancet publication reported 7 cases of children with fever, exanthema, hypotension and diarrhoea associated with multiple organ failure. An association between TSS and use of hyper-absorbent tampons in menstruating women was discovered in the 1980s. Following the market withdrawal of such tampons, TSS virtually disappeared. Herein we report a new case of TSS in a 15-year-old girl. PATIENTS AND METHODS: A 15-year-old patient was admitted to intensive care for severe sepsis and impaired consciousness associated with diffuse abdominal pain. Dermatological examination revealed diffuse macular exanthema. Laboratory tests showed hepatic cytolysis (ASAT 101 U/L, ALAT 167 U/L, total bilirubin 68µmol/L) and an inflammatory syndrome. Lumbar puncture and blood cultures were sterile while thoraco-abdomino-pelvic and brain scans were normal. The patient was menstruating and had been using a tampon over the previous 24hours. Vaginal sampling and tampon culture revealed TSST-1 toxin-producing S. aureus. Management consisted of intensive care measures and treatment with amoxicillin-clavulanic acid and clindamycin for 10 days. CONCLUSION: In case of septic shock associated with diffuse macular exanthema a diagnosis of TSS must be envisaged, particularly in menstruating women.


Subject(s)
Erythema/etiology , Fever of Unknown Origin/etiology , Shock, Septic/diagnosis , Shock/etiology , Abdominal Pain/etiology , Adolescent , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Bacterial Toxins/analysis , Clindamycin/therapeutic use , Critical Care , Diagnosis, Differential , Drug Therapy, Combination , Enterotoxins/analysis , Female , Humans , Menstrual Hygiene Products/adverse effects , Shock, Septic/therapy , Staphylococcus aureus/pathogenicity , Superantigens/analysis
SELECTION OF CITATIONS
SEARCH DETAIL